Anjeza Xholli

Current approaches to the diagnosis and management of retained products of conception and enhanced myometrial vascularity of the first trimester.

Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

Published: July 08, 2026

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: July 06, 2026

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: July 06, 2026

Bilateral Ovarian Anastomosing Hemangioma Mimicking Malignancy: A Frozen Section Diagnostic Pitfall.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: July 01, 2026

Re-evaluating desogestrel: hormonal contraception, early-onset breast cancer, and the postpartum period.

Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

Published: April 16, 2026

Vaginal Contraception With NuvaRing Decreases Symptoms and Uterine Features of Adenomyosis: A Prospective Evaluation.

Journal: Obstetrical & gynecological survey

Published: December 30, 2025

Hormonal contraception and breast cancer: the impact of formulation era, age, and ethnicity.

Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

Published: December 17, 2025

The impact of hormonal contraceptives containing estradiol, estradiol valerate, and estetrol on liver proteins, lipids, glucose, blood pressure, and bone. A literature review.

Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

Published: December 17, 2025

Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61".

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 20, 2025

Vaginal contraception with NuvaRing decreases symptoms and uterine features of adenomyosis: A prospective evaluation.

Journal: Contraception

Published: March 04, 2025

Current approaches to the diagnosis and management of retained products of conception and enhanced myometrial vascularity of the first trimester.

Current approaches to the diagnosis and management of retained products of conception and enhanced myometrial vascularity of the first trimester.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Bilateral Ovarian Anastomosing Hemangioma Mimicking Malignancy: A Frozen Section Diagnostic Pitfall.

Bilateral Ovarian Anastomosing Hemangioma Mimicking Malignancy: A Frozen Section Diagnostic Pitfall.

Re-evaluating desogestrel: hormonal contraception, early-onset breast cancer, and the postpartum period.

Re-evaluating desogestrel: hormonal contraception, early-onset breast cancer, and the postpartum period.

Vaginal Contraception With NuvaRing Decreases Symptoms and Uterine Features of Adenomyosis: A Prospective Evaluation.

Vaginal Contraception With NuvaRing Decreases Symptoms and Uterine Features of Adenomyosis: A Prospective Evaluation.

Hormonal contraception and breast cancer: the impact of formulation era, age, and ethnicity.

Hormonal contraception and breast cancer: the impact of formulation era, age, and ethnicity.

The impact of hormonal contraceptives containing estradiol, estradiol valerate, and estetrol on liver proteins, lipids, glucose, blood pressure, and bone. A literature review.

The impact of hormonal contraceptives containing estradiol, estradiol valerate, and estetrol on liver proteins, lipids, glucose, blood pressure, and bone. A literature review.

Cardiometabolic risk in women with polycystic ovary syndrome: a comprehensive review.

Cardiometabolic risk in women with polycystic ovary syndrome: a comprehensive review.

Neurokinin Antagonists to Treat Vasomotor Symptoms-Possible Implications for Long-Term Health and Disease.

Neurokinin Antagonists to Treat Vasomotor Symptoms-Possible Implications for Long-Term Health and Disease.

Vaginal contraception with NuvaRing decreases symptoms and uterine features of adenomyosis: A prospective evaluation.

Vaginal contraception with NuvaRing decreases symptoms and uterine features of adenomyosis: A prospective evaluation.